JESSICA OAKLEY: Open Payments
NPI 1255841383 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,873 in 85 payments from 16 companies in 2025. Trend: 2023 $2,222 · 2024 $2,335 · 2025 $1,873
Food & beverage: $1,778Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $612 |
| Regeneron Healthcare Solutions, Inc. | 4 | $223 |
| Amgen Inc. | 13 | $203 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $157 |
| Incyte Corporation | 5 | $145 |
| UCB, Inc. | 5 | $89 |
| GENZYME CORPORATION | 2 | $69 |
| E.R. Squibb & Sons, L.L.C. | 4 | $67 |
| Arcutis Biotherapeutics, Inc. | 4 | $65 |
| Galderma Laboratories, L.P. | 3 | $61 |
Products named: RINVOQ, DUPIXENT, OTEZLA, SKYRIZI, OPZELURA, Bimzelx, Sotyktu, Zoryve.
Industry payments across CA — which companies pay providers there.
